| An Bioequivalence Study to Compare 10mg & 20mg of Senaparib Capsules in Healthy Chinese Subjects Under Fasting Condition (NCT07019194) | Impact Therapeutics, Inc. | 2024-06-21 |
| An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition (NCT05390944) | Impact Therapeutics, Inc. | 2022-06-08 |
| An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition (NCT05391048) | Impact Therapeutics, Inc. | 2022-06-06 |
| Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors (NCT05269316) | Impact Therapeutics, Inc. | 2022-02-11 |
| Senaparib in mCRPC Patients With Homologous Recombination Repair Gene Alterations After Docetaxel Treatment (NCT04822961) | Impact Therapeutics, Inc. | 2021-12-31 |
| A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects (NCT05109832) | Impact Therapeutics, Inc. | 2021-10-09 |
| A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State (NCT07030439) | Impact Therapeutics, Inc. | 2021-07-18 |
| The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors (NCT04768868) | Impact Therapeutics, Inc. | 2021-02-25 |
| IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers (NCT04584515) | Impact Therapeutics, Inc. | 2020-11-02 |
| BA Study of IMP4297 (20mg vs 10mg) in Healthy Male Subjects (NCT04351165) | Impact Therapeutics, Inc. | 2020-10-29 |
| IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer (NCT04434482) | Impact Therapeutics, Inc. | 2020-08-07 |
| A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer (NCT04169997) | Impact Therapeutics, Inc. | 2019-12-24 |
| Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer (NCT04089189) | Impact Therapeutics, Inc. | 2019-10-28 |
| IMP4297 Food Effect Trial in Healthy Volunteers (NCT04057729) | Impact Therapeutics, Inc. | 2019-07-22 |